Insiders Tourmaline Bio, Inc.

Equities

TRML

US89157D1054

Real-time Estimate Cboe BZX Other stock markets 11:17:52 2024-05-08 EDT			5-day change	1st Jan Change
15.62 ^USD	-0.98%		+0.16%	-39.90%

04-25	Certain Restricted Stock Units of Tourmaline Bio, Inc. are subject to a Lock-Up Agreement Ending on 25-APR-2024.	CI
04-25	Certain Options of Tourmaline Bio, Inc. are subject to a Lock-Up Agreement Ending on 25-APR-2024.	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Tourmaline Bio Insider Bought Shares Worth $3,250,000, According to a Recent SEC Filing	01-31	MT
Tourmaline Bio, Inc. Appoints Clay Siegall to Serve as a Director	12-14	CI
Tourmaline Bio, Inc. Announces Resignation of Cariad Chester as Member of the Board of Directors	11-30	CI
Tourmaline Bio Insider Bought Shares Worth $280,584, According to a Recent SEC Filing	23-10-27	MT
Tourmaline Bio Insider Bought Shares Worth $110,912, According to a Recent SEC Filing	23-10-26	MT
Insider Sell: Talaris Therapeutics	23-06-15	MT
Insider Sell: Talaris Therapeutics	23-06-09	MT
Talaris Therapeutics Names Mary Kay Fenton Interim Chief Executive	23-05-26	MT
Talaris Therapeutics, Inc. Announces Executive Changes	23-05-26	CI
Talaris Therapeutics, Inc. Appoints Mary Kay Fenton as President	23-05-26	CI
Insider Sell: Talaris Therapeutics	23-04-21	MT
Insider Sell: Talaris Therapeutics	23-04-19	MT
Talaris Therapeutics, Inc. Announces the Resignation of Scott Requadt as Chief Executive Officer, Effective May 26, 2023	23-04-14	CI
Talaris Therapeutics, Inc. Announces Executive Resignation	23-04-14	CI
Insider Sell: Talaris Therapeutics	22-08-24	MT
Talaris Therapeutics, Inc. Announces Transition of Suzanne Ildstad as CSO to Being A Senior Scientific Advisor, Effective to Being A Senior Scientific Advisor	22-08-15	CI
Insider Buy: Talaris Therapeutics	22-08-02	MT
Talaris Therapeutics, Inc. Announces Board Changes	22-05-17	CI
Talaris Therapeutics, Inc. Appoints Mary Kay Fenton as Chief Financial Officer	21-03-04	CI
Talaris Therapeutics, Inc. Announces Board and Committee Appointments	21-01-29	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Tourmaline Bio, Inc.

Equities

TRML

US89157D1054

Insiders

Filters